TP53 and acute myeloid leukemia: P53 loss of function resulting from chromosomal losses of 17p region and TP53 gene mutations result in marked chemorefractoriness and very poor prognosis, with virtually incurability for most patients treated with conventional AML chemotherapy [24, 25, 28, 29].